Related Experiment Video
Updated: Oct 16, 2025
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.6K
A Rapid and Highly Sensitive Chemiluminescent Method to Quantify HPV16E7 Antibody Based on Immunomagnetic Separation
Clinical Laboratory
|October 16, 2021
Summary
A novel chemiluminescence immunoassay (CLIA) using immunomagnetic separation (IMS) offers a sensitive and rapid method for detecting anti-HPV16E7 antibodies in serum. This technique demonstrates excellent performance for potential clinical applications.
Area of Science:
- Biotechnology
- Immunology
- Analytical Chemistry
Background:
- Development of a novel, sensitive chemiluminescence immunoassay (CLIA) for detecting human papillomavirus (HPV) type 16 E7 (HPV16E7) antibodies.
- Need for rapid and highly sensitive diagnostic methods for HPV infection detection.
Purpose of the Study:
- To introduce a novel, sensitive chemiluminescence immunoassay (CLIA) combined with immunomagnetic separation (IMS) for detecting anti-HPV16E7 antibodies in serum.
- To evaluate the performance and stability of the developed CLIA-IMS method.
Main Methods:
- Preparation and validation of monoclonal antibodies against HPV16E7.
- Development of biotinylated HPV16E7 antigen on immunomagnetic beads (IMBs) for antigen capture.
- Utilizing horseradish peroxidase (HRP)-labeled antibodies and a chemiluminescent substrate for signal generation and detection via luminometry.
Main Results:
- Successful preparation and validation of HPV16E7 monoclonal antibodies.
- Efficient antigen binding to IMBs with a 72% conjugation rate and stable biological activity for up to 2 months.
- Excellent sensitivity and stability demonstrated, with a good linear relationship (R² = 0.9952) for quantitative measurement.
Conclusions:
- The developed CLIA-IMS technique exhibits excellent performance for the quantitative measurement of HPV16E7 antibodies.
- The method shows significant potential for application in clinical diagnostics for HPV infection.
